Haemonetics (HAE) Tops Q3 EPS by 4c, Revenues Miss; Offers FY19 EPS Mid-Point Guidance Below Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. SPCX
3. MU
4. SPY
5. ACN
6. IBM
7. PRIM
8. PFE
9. TSLA
10. DPZ

Go back to Haemonetics (HAE) Tops Q3 EPS by 4c, Revenues Miss; Offers FY19 EPS Mid-Point Guidance Below Consensus

Haemonetics (HAE) Sell-Off Overdone - Jefferies

February 5, 2019 12:40 PM EST

Jefferies analyst Anthony Petrone came out to defend Haemonetics (NYSE: HAE) calling the sell-off overdone and providing a good entry point.

The high-level sticking points are: 1) implicit plasma guide for F2020; 2) pace of NexSys contracting; and 3) level of spend in Q and... More